Completed NA NCT00002236

A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients

An Open-Label, Parallel Group, Pilot Study of Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of BID and TID Regimens of Delavirdine Mesylate, Zidovudine, and Indinavir Sulfate in HIV-1 Infected Individuals

Sponsor: Pharmacia and Upjohn

Conditions HIV Infections

Interventions Delavirdine mesylate Indinavir sulfate Zidovudine

Updated 5 times since 2017 Last updated: Jun 23, 2005

A NA clinical study on HIV Infections, this trial is completed. The trial is conducted by Pharmacia and Upjohn and has accumulated 5 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pharmacia and Upjohn

Data source: NIH AIDS Clinical Trials Information Service

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Annandale, United States
• Los Angeles, United States
• Memphis, United States
• New York, United States
• Pittsburgh, United States
• San Francisco, United States

Related Trials

By Sponsor 10

Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E
Shared: Pharmacia and Upjohn

Completed
Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals
Shared: Pharmacia and Upjohn

Completed
A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients
Shared: Pharmacia and Upjohn

Completed
A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3
Shared: Pharmacia and Upjohn

Completed
A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3
Shared: Pharmacia and Upjohn

Completed
The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine
Shared: Pharmacia and Upjohn

Completed
A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies
Shared: Pharmacia and Upjohn

Completed
A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
Shared: Pharmacia and Upjohn

Completed
Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients
Shared: Pharmacia and Upjohn

Completed
A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients
Shared: Pharmacia and Upjohn

Completed

By Intervention 10

A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy
Shared: Delavirdine mesylate

Completed
Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection
Shared: Indinavir sulfate

Terminated
Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults
Shared: Indinavir sulfate

Completed
Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)
Shared: Delavirdine mesylate

Completed
A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
Shared: Indinavir sulfate

Completed
The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year
Shared: Indinavir sulfate

Completed
The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy
Shared: Indinavir sulfate

Completed
The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients
Shared: Indinavir sulfate

Completed
A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
Shared: Indinavir sulfate

Completed
A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3
Shared: Indinavir sulfate

Completed

By Location 10

Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
Shared: Annandale, United States

Completed
A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS
Shared: Annandale, United States

Completed
A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine
Shared: Annandale, United States

Completed
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS
Shared: Annandale, United States

Completed
A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
Shared: Annandale, United States

Completed
Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients
Shared: Annandale, United States

Completed
Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
Shared: Annandale, United States

Completed
A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo
Shared: Annandale, United States

Completed
Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
Shared: Annandale, United States

Completed
A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients
Shared: Annandale, United States

Completed